Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Kedudukan dalam Saham #25795
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Harga Saham
$4.80
Modal Pasaran
$46.24M
Perubahan (1 hari)
-16.52%
Perubahan (1 tahun)
103.39%
Negara
CA
Perdagangan Edesa Biotech, Inc. (EDSA)

Kategori

Sejarah harga saham bagi Edesa Biotech, Inc. (EDSA)
Harga penutupan tertinggi: $5.37 pada 2026-08-01

Harga penutupan terendah: $602.70 pada 2010-06-01
Sejarah harga saham Edesa Biotech, Inc. dari 2010 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 188.73%
2025 -16.90%
2024 -58.03%
2023 -48.53%
2022 -77.76%
2021 16.75%
2020 12.06%
2019 -29.49%
2018 -84.76%
2017 -54.18%
2016 -73.20%
2015 -32.44%
2014 -36.36%
2013 592.43%
2012 -41.11%
2011 -62.20%
2010 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US